Join
Live feed
·
SECFilingvia Quantisnow
Dianthus Therapeutics Inc. logo

Dianthus Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
DNTH· Dianthus Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNTH (Dianthus Therapeutics Inc.) and more on Quantisnow.